FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113998466> ?p ?o ?g. }

• W2113998466 endingPage "387" @default.
• W2113998466 startingPage "378" @default.
• W2113998466 abstract "Abstract Learning Objectives After completing this course, the reader will be able to: Define the potential risks of chemotherapy and evaluate the relationship between multiple comorbid conditions and the likelihood of experiencing these risks.Describe a process for tracking severe chemotherapy toxicity in a patient population, enumerate the barriers to implementation, and describe ways to overcome the barriers. This article is available for continuing medical education credit at CME.TheOncologist.com Purpose. To describe the frequency, nature, trends, predictors, and outcomes of chemotherapy-related hospitalizations (CRHs) among a nonselected population of cancer patients treated at a community cancer center, and to explore the feasibility of implementing continuous quality improvement methodologies in routine oncology practice. Methods. We conducted a prospective cohort study of consecutive adult cancer patients who received chemotherapy at a community cancer center January 2003 to December 2006. Demographic, comorbidity, diagnosis, treatment, and laboratory data were collected via medical record abstraction. Hospitalizations were classified as chemotherapy related or unrelated by a multidisciplinary panel. Patients who experienced CRHs were compared with those who did not. Using a randomly sampled subset of cases and controls, we built a logistic regression model to identify independent predictors of CRH. Results. Of 2,068 chemotherapy recipients, 179 (8.7%) experienced 262 CRHs. Most hospitalizations were not chemotherapy related (73.7%). The mean monthly rate of CRH was 1.5%, the median length of stay was 5 days, the most common type of CRH was gastrointestinal (46.1%) followed by infectious (31.4%), and 0.9% of chemotherapy recipients had a fatal CRH. Significant predictors of CRH included having a comorbidity score of 3–4 versus 0 and having a higher creatinine level. Conclusions. Although the vast majority of chemotherapy recipients did not experience a CRH, these events were, unfortunately, not without serious consequences. Care should be taken when offering chemotherapy to patients with multiple comorbid conditions. Systematic efforts to monitor toxicity can lead directly to improvements in quality of care." @default.
• W2113998466 created "2016-06-24" @default.
• W2113998466 creator A5008311698 @default.
• W2113998466 creator A5023086480 @default.
• W2113998466 creator A5024918720 @default.
• W2113998466 creator A5026034059 @default.
• W2113998466 creator A5037393862 @default.
• W2113998466 creator A5054056965 @default.
• W2113998466 creator A5074929378 @default.
• W2113998466 date "2011-02-24" @default.
• W2113998466 modified "2023-09-26" @default.
• W2113998466 title "Chemotherapy-Related Hospitalization Among Community Cancer Center Patients" @default.
• W2113998466 cites W1596212760 @default.
• W2113998466 cites W1921920391 @default.
• W2113998466 cites W1948961602 @default.
• W2113998466 cites W1972787599 @default.
• W2113998466 cites W1996129969 @default.
• W2113998466 cites W2000034135 @default.
• W2113998466 cites W2000445173 @default.
• W2113998466 cites W2017256771 @default.
• W2113998466 cites W2025893217 @default.
• W2113998466 cites W2046289412 @default.
• W2113998466 cites W2051859609 @default.
• W2113998466 cites W2074048861 @default.
• W2113998466 cites W2076668534 @default.
• W2113998466 cites W2097771589 @default.
• W2113998466 cites W2099199992 @default.
• W2113998466 cites W2100346414 @default.
• W2113998466 cites W2102235447 @default.
• W2113998466 cites W2102417626 @default.
• W2113998466 cites W2119463649 @default.
• W2113998466 cites W2142389745 @default.
• W2113998466 cites W2142498324 @default.
• W2113998466 cites W2150906637 @default.
• W2113998466 cites W2151595445 @default.
• W2113998466 cites W2152845541 @default.
• W2113998466 cites W2153972688 @default.
• W2113998466 cites W2158094974 @default.
• W2113998466 cites W2162915723 @default.
• W2113998466 cites W2169432501 @default.
• W2113998466 doi "https://doi.org/10.1634/theoncologist.2010-0354" @default.
• W2113998466 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3228109" @default.
• W2113998466 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21349949" @default.
• W2113998466 hasPublicationYear "2011" @default.
• W2113998466 type Work @default.
• W2113998466 sameAs 2113998466 @default.
• W2113998466 citedByCount "57" @default.
• W2113998466 countsByYear W21139984662012 @default.
• W2113998466 countsByYear W21139984662013 @default.
• W2113998466 countsByYear W21139984662014 @default.
• W2113998466 countsByYear W21139984662015 @default.
• W2113998466 countsByYear W21139984662016 @default.
• W2113998466 countsByYear W21139984662017 @default.
• W2113998466 countsByYear W21139984662018 @default.
• W2113998466 countsByYear W21139984662019 @default.
• W2113998466 countsByYear W21139984662020 @default.
• W2113998466 countsByYear W21139984662021 @default.
• W2113998466 countsByYear W21139984662022 @default.
• W2113998466 countsByYear W21139984662023 @default.
• W2113998466 crossrefType "journal-article" @default.
• W2113998466 hasAuthorship W2113998466A5008311698 @default.
• W2113998466 hasAuthorship W2113998466A5023086480 @default.
• W2113998466 hasAuthorship W2113998466A5024918720 @default.
• W2113998466 hasAuthorship W2113998466A5026034059 @default.
• W2113998466 hasAuthorship W2113998466A5037393862 @default.
• W2113998466 hasAuthorship W2113998466A5054056965 @default.
• W2113998466 hasAuthorship W2113998466A5074929378 @default.
• W2113998466 hasBestOaLocation W21139984661 @default.
• W2113998466 hasConcept C121608353 @default.
• W2113998466 hasConcept C126322002 @default.
• W2113998466 hasConcept C143998085 @default.
• W2113998466 hasConcept C151956035 @default.
• W2113998466 hasConcept C177713679 @default.
• W2113998466 hasConcept C188816634 @default.
• W2113998466 hasConcept C194828623 @default.
• W2113998466 hasConcept C195910791 @default.
• W2113998466 hasConcept C201903717 @default.
• W2113998466 hasConcept C2776694085 @default.
• W2113998466 hasConcept C2779159551 @default.
• W2113998466 hasConcept C2908647359 @default.
• W2113998466 hasConcept C71924100 @default.
• W2113998466 hasConcept C72563966 @default.
• W2113998466 hasConcept C99454951 @default.
• W2113998466 hasConceptScore W2113998466C121608353 @default.
• W2113998466 hasConceptScore W2113998466C126322002 @default.
• W2113998466 hasConceptScore W2113998466C143998085 @default.
• W2113998466 hasConceptScore W2113998466C151956035 @default.
• W2113998466 hasConceptScore W2113998466C177713679 @default.
• W2113998466 hasConceptScore W2113998466C188816634 @default.
• W2113998466 hasConceptScore W2113998466C194828623 @default.
• W2113998466 hasConceptScore W2113998466C195910791 @default.
• W2113998466 hasConceptScore W2113998466C201903717 @default.
• W2113998466 hasConceptScore W2113998466C2776694085 @default.
• W2113998466 hasConceptScore W2113998466C2779159551 @default.
• W2113998466 hasConceptScore W2113998466C2908647359 @default.
• W2113998466 hasConceptScore W2113998466C71924100 @default.
• W2113998466 hasConceptScore W2113998466C72563966 @default.
• W2113998466 hasConceptScore W2113998466C99454951 @default.

• next